People In The News

NEW YORK (GenomeWeb News) – 23andMe Co-founder Linda Avey has left the personal genomics services company to start a foundation that will focus on Alzheimer's disease. The foundation Avey will run will use the 23andMe research platform to search for causes of and treatments for the disease.

Avey's departure was effective as of Sept. 4, the day the announcement was made.

Avey and co-founder Anne Wojcicki started the company together around three years ago.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.

Wired reports that 23andMe is trying to bolster its outside collaborations.